Gene · 3601
Papers2,328
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,328
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A novel anti-PD-L1/IL-15 immunocytokine overcomes resistance to PD-L1 blockade and elicits potent antitumor immunity. | Mol Ther | 2023 | 36045584 | PubTator, text mining | PubMed |
| VG161 activates systemic antitumor immunity in pancreatic cancer models as a novel oncolytic herpesvirus expressing multiple immunomodulatory transgenes. | J Med Virol | 2023 | 36042555 | PubTator, text mining | PubMed |
| Chromosomal Numerical Aberrations and Rare Copy Number Variation in Patients with Inflammatory Bowel Disease. | J Crohns Colitis | 2023 | 35907265 | PubTator, text mining | PubMed |
| Improving NK cell function in multiple myeloma with NKTR-255, a novel polymer-conjugated human IL-15. | Blood Adv | 2023 | 35882498 | PubTator, text mining | PubMed |
| Exploration of the breast ductal carcinoma in situ signature and its prognostic implications. | Cancer Med | 2023 | 35880695 | PubTator, text mining | PubMed |
| Circulating cytokine profile and modulation of regulatory T cells in chronic hepatitis B patients with type 2 diabetes mellitus. | Biomol Biomed | 2023 | 35801423 | PubTator, text mining | PubMed |
| Transcriptomic analysis in zebrafish larvae identifies iron-dependent mitochondrial dysfunction as a possible key event of NAFLD progression induced by benzo[a]pyrene/ethanol co-exposure. | Cell Biol Toxicol | 2023 | 35412187 | PubTator, text mining | PubMed |
| Molecular and cellular factors determining the functional pleiotropy of cytokines. | FEBS J | 2023 | 35246947 | PubTator, text mining | PubMed |
| The remodeling roles of lipid metabolism in colorectal cancer cells and immune microenvironment. | Oncol Res | 2022 | 37305350 | PubTator, text mining | PubMed |
| Identification and validation of a muscle failure index to predict prognosis and immunotherapy in lung adenocarcinoma through integrated analysis of bulk and single-cell RNA sequencing data. | Front Immunol | 2022 | 36733390 | PubTator, text mining | PubMed |
| The crosstalk between the gut microbiota and tumor immunity: Implications for cancer progression and treatment outcomes. | Front Immunol | 2022 | 36726985 | PubTator, text mining | PubMed |
| Heterodimeric IL-15 (hetIL-15) reduces circulating tumor cells and metastasis formation improving chemotherapy and surgery in 4T1 mouse model of TNBC. | Front Immunol | 2022 | 36713398 | PubTator, text mining | PubMed |
| [Progress in chimeric antigen receptor NK cell therapy for hematological malignancies]. | Zhonghua Xue Ye Xue Za Zhi | 2022 | 36709115 | PubTator, text mining | PubMed |
| Dendritic cells and natural killer cells: The road to a successful oncolytic virotherapy. | Front Immunol | 2022 | 36703982 | PubTator, text mining | PubMed |
| CAR T cell therapy becomes CHIC: "cytokine help intensified CAR" T cells. | Front Immunol | 2022 | 36700225 | PubTator, text mining | PubMed |
| Contribution of natural killer cells in innate immunity against colorectal cancer. | Front Oncol | 2022 | 36686835 | PubTator, text mining | PubMed |
| Interleukin-15 and chemokine ligand 19 enhance cytotoxic effects of chimeric antigen receptor T cells using zebrafish xenograft model of gastric cancer. | Front Immunol | 2022 | 36618357 | PubTator, text mining | PubMed |
| Intrinsic and Extrinsic Transcriptional Profiles That Affect the Clinical Response to PD-1 Inhibitors in Patients with Non-Small Cell Lung Cancer. | Cancers (Basel) | 2022 | 36612193 | PubTator, text mining | PubMed |
| The Cytokine Network in Colorectal Cancer: Implications for New Treatment Strategies. | Cells | 2022 | 36611932 | PubTator, text mining | PubMed |
| PTPRK, an EGFR Phosphatase, Is Decreased in CeD Biopsies and Intestinal Organoids. | Cells | 2022 | 36611909 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3601/papers?page=20